Sweden· SE-20231031000101
Antabus 400 mg Brustablett
A medicinal product containing disulfiram, registered in Sweden by Medartuum AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Disulfiram
- Manufacturer
- Medartuum AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20231031000101
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Disulfiram in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANTABUSTeva B.V., Haarlem
- SwitzerlandAntabus Dispergetten
- IrelandAntabuse 400 mg Effervescent TabletsTeva B.V.
- IcelandAntabusTeva B.V.*
- United KingdomAntabuse 200mg tabletsActavis UK Ltd
- United StatesDisulfiramChartwell RX, LLC
- NorwayAntabus
- PolandAnticolZakłady Farmaceutyczne POLPHARMA S.A.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Czechia · Antabus
- Germany · Tetraethylthiuramdisulfid Smartpractice Europe
- Denmark · Antabus
- Spain · Antabus
- Finland · Antabus
- France · Esperal
- United Kingdom (Northern Ireland) · Antabuse, Disulfiram Accord-Uk
- Hungary · Antaethyl
- Ireland · Antabuse
- Iceland · Antabus
- Italy · Antabuse Dispergettes, Etiltox
- Malta · Disural
- Netherlands · Disulfiram Aurobindo, Refusal
- Norway · Antabus
- Poland · Anticol, Disulfiram Wzf
- Portugal · Tetradin
- Romania · Antalcol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edd1f3a4-e863-4ff3-9e9c-148deef648a7 GET /v1/drugs/edd1f3a4-e863-4ff3-9e9c-148deef648a7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20231031000101",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20231031000101",
"product_doc_link": "https://docetp.mpa.se/LMF/Antabus%20400%20mg%20effervescent%20tablet%20IT%20PL_09001bee83b0eb1d.pdf"
}See everything about disulfiram.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.